| CereVasc Completes Enrollment of ETCHES Study of the eShunt® System for the Treatment of Communicating Hydrocephalus Landmark study demonstrates safety and performance of the eShunt System in the treatment of communicating hydrocephalus BOSTON, Jan. 21, 2026 /PRNewswire/ – CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced the completion […] The post CereVasc Completes Enrollment of ETCHES Study of the eShunt® System for the Treatment of Communicating Hydrocephalus appeared first on CereVasc |
Ne |
